Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolomics Analysis for Biomarker Discovery: Advances and Challenges
Márcia Monteiro, Márcia Carvalho, Maria de Lourdes Bastos, et al.
Current Medicinal Chemistry (2013) Vol. 20, Iss. 2, pp. 257-271
Closed Access | Times Cited: 250

Showing 1-25 of 250 citing articles:

The growing role of precision and personalized medicine for cancer treatment
Paulina Krzyszczyk, Alison Acevedo, Erika J. Davidoff, et al.
Deleted Journal (2018) Vol. 06, Iss. 03n04, pp. 79-100
Open Access | Times Cited: 470
Livestock metabolomics and the livestock metabolome: A systematic review
Seyed Ali Goldansaz, An Chi Guo, Tanvir Sajed, et al.
PLoS ONE (2017) Vol. 12, Iss. 5, pp. e0177675-e0177675
Open Access | Times Cited: 288
Mass spectrometric based approaches in urine metabolomics and biomarker discovery
Mona M. Khamis, Darryl J. Adamko, Anas El‐Aneed
Mass Spectrometry Reviews (2015) Vol. 36, Iss. 2, pp. 115-134
Open Access | Times Cited: 278
Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a review
Abdul‐Hamid Emwas, Claudio Luchinat, Paola Turano, et al.
Metabolomics (2014) Vol. 11, Iss. 4, pp. 872-894
Open Access | Times Cited: 216
Metabolomics for the masses: The future of metabolomics in a personalized world
Drupad K. Trivedi, Katherine A. Hollywood, Royston Goodacre
European Journal of Molecular & Clinical Medicine (2017) Vol. 3, Iss. 6, pp. 294-294
Open Access | Times Cited: 174
Statistical Methods for Handling Unwanted Variation in Metabolomics Data
Alysha De Livera, Marko Sysi‐Aho, Laurent Jacob, et al.
Analytical Chemistry (2015) Vol. 87, Iss. 7, pp. 3606-3615
Open Access | Times Cited: 174
“Omics”-Informed Drug and Biomarker Discovery: Opportunities, Challenges and Future Perspectives
Holly Matthews, James Hanison, Niroshini Nirmalan
Proteomes (2016) Vol. 4, Iss. 3, pp. 28-28
Open Access | Times Cited: 161
Advantages and Pitfalls of Mass Spectrometry Based Metabolome Profiling in Systems Biology
Ina Aretz, David Meierhofer
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 5, pp. 632-632
Open Access | Times Cited: 144
Metabolomics in the study of retinal health and disease
Inês Laíns, Mari Gantner, Salome Murinello, et al.
Progress in Retinal and Eye Research (2018) Vol. 69, pp. 57-79
Closed Access | Times Cited: 136
Metabolic alterations in urine extracellular vesicles are associated to prostate cancer pathogenesis and progression
Marc Clos-García, Ana Loizaga‐Iriarte, Patricia Zúñiga-García, et al.
Journal of Extracellular Vesicles (2018) Vol. 7, Iss. 1
Open Access | Times Cited: 132
Biomarker Discovery in Human Prostate Cancer: an Update in Metabolomics Studies
Ana Rita Lima, Maria de Lourdes Bastos, Márcia Carvalho, et al.
Translational Oncology (2016) Vol. 9, Iss. 4, pp. 357-370
Open Access | Times Cited: 126
Metabolomic strategies for the identification of new enzyme functions and metabolic pathways
Gareth A. Prosser, Gerald Larrouy‐Maumus, Luiz Pedro S. de Carvalho
EMBO Reports (2014) Vol. 15, Iss. 6, pp. 657-669
Open Access | Times Cited: 124
Blood biomarkers in ischemic stroke: potential role and challenges in clinical practice and research
Konstantinos Makris, Alexander Haliassos, Maria Chondrogianni, et al.
Critical Reviews in Clinical Laboratory Sciences (2018) Vol. 55, Iss. 5, pp. 294-328
Closed Access | Times Cited: 114
TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics
M Gupta, Drew Neavin, Duan Liu, et al.
Molecular Psychiatry (2016) Vol. 21, Iss. 12, pp. 1717-1725
Open Access | Times Cited: 112
Metabolomic Strategies in Biomarker Research–New Approach for Indirect Identification of Drug Consumption and Sample Manipulation in Clinical and Forensic Toxicology?
Andrea E. Steuer, Lana Brockbals, Thomas Kræmer
Frontiers in Chemistry (2019) Vol. 7
Open Access | Times Cited: 110
Development of a Universal Metabolome-Standard Method for Long-Term LC–MS Metabolome Profiling and Its Application for Bladder Cancer Urine-Metabolite-Biomarker Discovery
Jun Peng, Yi‐Ting Chen, Chien‐Lun Chen, et al.
Analytical Chemistry (2014) Vol. 86, Iss. 13, pp. 6540-6547
Closed Access | Times Cited: 100
Cancer models in preclinical research: A chronicle review of advancement in effective cancer research
Humna Sajjad, Saiqa Imtiaz, Tayyaba Nооr, et al.
Animal Models and Experimental Medicine (2021) Vol. 4, Iss. 2, pp. 87-103
Open Access | Times Cited: 100
Serum Metabolomics Study of Papillary Thyroid Carcinoma Based on HPLC-Q-TOF-MS/MS
Yang Du, Peizhi Fan, Lianhong Zou, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 58
Transcriptome and metabolome profiling unveil the accumulation of flavonoids in Dendrobium officinale
Yingdan Yuan, Jiajia Zuo, Hanyue Zhang, et al.
Genomics (2022) Vol. 114, Iss. 3, pp. 110324-110324
Open Access | Times Cited: 41
Metabolomic analysis reveals potential biomarkers and the underlying pathogenesis involved in Mycoplasma pneumoniae pneumonia
Jieqiong Li, Laurence Don Wai Luu, Xiaoxia Wang, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 593-605
Open Access | Times Cited: 39
Canine Mammary Tumors: Classification, Biomarkers, Traditional and Personalized Therapies
Natália Nosálová, Mykhailo Huniadi, Ľubica Horňáková, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2891-2891
Open Access | Times Cited: 13
Artificial intelligence in metabolomics: a current review
Jinhua Chi, Jingmin Shu, Ming Li, et al.
TrAC Trends in Analytical Chemistry (2024) Vol. 178, pp. 117852-117852
Closed Access | Times Cited: 13
Microbiota Implications in Endocrine-Related Diseases: From Development to Novel Therapeutic Approaches
Vicente Javier Clemente‐Suárez, Laura Redondo-Flórez, Alejandro Rubio-Zarapuz, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 221-221
Open Access | Times Cited: 12
Challenges in the Metabolomics-Based Biomarker Validation Pipeline
Shenghan Li, Nikita Looby, Vinod Chandran, et al.
Metabolites (2024) Vol. 14, Iss. 4, pp. 200-200
Open Access | Times Cited: 8
Comprehensive, Quantitative Analysis of SRM 1950: the NIST Human Plasma Reference Material
Rupasri Mandal, Jiamin Zheng, Lun Zhang, et al.
Analytical Chemistry (2025)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top